Anixa Biosciences Inc (ANIX) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jul 31 2026 to Jul 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Anixa Biosciences Inc   (NASDAQ: ANIX)


Anixa Biosciences Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Anixa Biosciences Inc's ROI in the third quarter of 2026?
Anixa Biosciences Inc recorded a cumulative net loss of $-10 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -81.71%.

Within the Healthcare sector 576 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3890 to 3940.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jul 31 2026)
III. Quarter		 (Apr 30 2026)
II. Quarter		 (Jan 31 2026)
I. Quarter		 (Oct 31 2025)
IV. Quarter		 (Jul 31 2025)
III. Quarter
Y / Y Investment Change TTM -17.5 % -22.54 % -28.06 % -30.41 % -28.2 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 13 12 13 13 14
Return On Investment (TTM) -81.71 % -77.4 % -76.85 % -77.34 % -72.25 %
ANIX's Overall Ranking # 3940 # 3890 # 3470 # 3660 # 3529
Seq. Investment Change TTM -2.05 % -3.35 % -5.09 % -8.18 % -8.03 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -10 -10 -10 -11 -11

ANIX Company Profile >> Back to ANIX Roi Comparisons >> See Annual ANIX Return On Investment



Return On Investment ANIX's Ranking
Within: No.
Industry # 257
Sector # 577
Overall # 3940

Return On Investment Statistics
High Average Low
-13.67 %
-157.75 %
-1628.4 %
(Oct 31 2015)   (Apr 30 2014)







Financial Statements
Anixa Biosciences Inc's III. Quarter Investments $ 13 Millions ANIX's Balance sheet
Anixa Biosciences Inc's III. Quarter Income $ -3 Millions Quarterly ANIX's Income Statement
ANIX's Income by Division See ANIX's Income by Division


ANIX Annual Return On Investment (Oct 31 2025)
2025		 (Oct 31 2024)
2024		 (Oct 31 2023)
2023		 (Oct 31 2022)
2022		 (Oct 31 2020)
2020
Total Investments in Millions 13 18 23 28 8
Y / Y Investment Growth -28.25 % -20.18 % -18.16 % 254.4 % 76.96 %
Net Income in Millions -11 -13 -10 -14 -10
Y / Y Net Income Growth - - - - -
Annual Return On Investment -85.48 % -70.62 % -44.08 % -50.03 % -129.93 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ANIX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ANIX's Competitors
Subscribers only: Roi for Anixa Biosciences Inc's Suppliers
Subscribers only: Return On Investment for ANIX's Customers

Other Ratios
ANIX's Roa ANIX's Inventory Turnover Ratio ANIX's Growth Rates ANIX's Dividend Statistics
ANIX's Profitability Ratios ANIX's Asset Turnover Ratio ANIX's Dividend Growth
ANIX's Roe ANIX's Valuation Ratios ANIX's Financial Strength Ratios ANIX's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-17T09:30:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.